Literature DB >> 32311275

Roux-en-Y Gastric Bypass for Obesity. How We Do It.

Kamil Nurczyk1,2, Fernando A Herbella3, Marco G Patti1,4.   

Abstract

In 1994, Wittgrove and Clark first described the laparoscopic technique for the Roux-en-Y gastric bypass. Many techniques have been used over the years, mostly based on the use of linear and circular stapling devices for the two anastomoses-the jejeunojejunostomy and the gastrojejunostomy. In 2000, Dr. Kelvin Higa from Fresno described a different technique, with the performance of a hand-sewn gastrojejunostomy. In this article we do review our technique, which is based on Dr. Higa's initial description. The steps of the operation will be illustrated by intraoperative pictures.

Entities:  

Keywords:  Roux-en-Y gastric bypass; bariatric surgery; gastrojejunostomy; morbid obesity; sleeve gastrectomy; weight loss

Year:  2020        PMID: 32311275     DOI: 10.1089/lap.2020.0156

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  3 in total

1.  The gastro-jejunal anastomosis site influences dumping syndrome and weight regain in patients with obesity undergoing Laparoscopic Roux-en-Y Gastric Bypass.

Authors:  Dario Tuccinardi; Vincenzo Bruni; Rossella D'Alessio; Mikiko Watanabe; Ida Francesca Gallo; Silvia Manfrini
Journal:  Eat Weight Disord       Date:  2020-10-12       Impact factor: 4.652

2.  Following Roux-en-Y gastric bypass surgery, serum ceramides demarcate patients that will fail to achieve normoglycemia and diabetes remission.

Authors:  Annelise M Poss; Benjamin Krick; J Alan Maschek; Benjamin Haaland; James E Cox; Prasoona Karra; Anna R Ibele; Steven C Hunt; Ted D Adams; William L Holland; Mary C Playdon; Scott A Summers
Journal:  Med (N Y)       Date:  2022-06-15

Review 3.  Follow-up after bariatric surgery: are we effective enough?

Authors:  Kamil Nurczyk; Chia-En Chan; Tomasz Skoczylas; Grzegorz Wallner
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-11-01       Impact factor: 1.627

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.